WEX Releases Third Environmental, Social, and Governance Report Chronicling Progress and Providing a Glimpse into Future Sustainability Endeavors

WEX Releases Third Environmental, Social, and Governance Report Chronicling Progress and Providing a Glimpse into Future Sustainability Endeavors

The ESG report demonstrates a continued devotion to maintaining a culture that reflects the company’s core values, leading the mixed-fleet transition, managing its environmental footprint, and improving the welfare of communities across the countries where WEX operates.

PORTLAND, Maine–(BUSINESS WIRE)–WEX (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today published its third annual environmental, social, and governance (ESG) report. The report captures WEX’s ongoing ESG strategy and performance throughout 2022 across a team that has grown to more than 6,600 employees in 16 countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801096286/en/

"In the wake of changes in our economies, businesses, and communities over the last three years, WEX and our global customers and partners have continually adapted and evolved, and we aim to support them as they embrace initiatives such as transitioning to electric vehicles or educating consumers about the value of Health Savings Accounts,” said Melissa Smith, Chair and CEO, WEX (NYSE: WEX). (Photo: Business Wire)

“In the wake of changes in our economies, businesses, and communities over the last three years, WEX and our global customers and partners have continually adapted and evolved, and we aim to support them as they embrace initiatives such as transitioning to electric vehicles or educating consumers about the value of Health Savings Accounts,” said Melissa Smith, Chair and CEO, WEX (NYSE: WEX). (Photo: Business Wire)

This report organizes WEX’s efforts around its four core strategic ESG pillars – People and Culture, Environmental Innovation, Environmental Stewardship, and Social Impact – supplemented by key governance practices.

“In the wake of changes in our economies, businesses, and communities over the last three years, WEX and our global customers and partners have continually adapted and evolved, and we aim to support them as they embrace initiatives such as transitioning to electric vehicles or educating consumers about the value of Health Savings Accounts,” said Melissa Smith, Chair and CEO, WEX. “Executing a robust ESG strategy is embedded throughout our culture, driving long-term business success while making a positive impact. Our Board of Directors and executive leadership team provide dedicated oversight, ensuring WEX’s position as a responsible and successful leader.”

The full report is available at: www.wexinc.com/about/wex-esg-report/.

About WEX

WEX (NYSE: WEX) is the global commerce platform that simplifies the business of running a business. WEX has created a powerful ecosystem that offers seamlessly embedded, personalized solutions for its customers around the world. Through its rich data and specialized expertise in simplifying benefits, reimagining mobility, and paying and getting paid, WEX aims to make it easy for companies to overcome complexity and reach their full potential. For more information, please visit www.wexinc.com.

Forward-Looking Statements

This press release and the ESG Report referred to herein contain forward-looking statements, including statements that relate to the anticipated electric vehicle transition, as well as the Company’s DEI Business Aspirations, ESG targets, goals, and other commitments outlined in this press release and the ESG Report. Any statements that are not statements of historical facts may be deemed to be forward-looking statements. When used in this release and the ESG Report referred to herein, the words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “seeks,” “will,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such words. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially, including the risks and uncertainties identified in Item 1A of WEX’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 28, 2023 and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, filed with the SEC on April 27, 2023 and July 27, 2023, respectively, and any subsequent SEC filings. The forward-looking statements speak only as of the date of this release and undue reliance should not be placed on these statements. WEX disclaims any obligation to update any forward-looking statements as a result of new information, future events or otherwise.

WEX Media

[email protected]

KEYWORDS: United States North America Maine

INDUSTRY KEYWORDS: Professional Services Environmental, Social and Governance (ESG) Business Environment Technology Sustainability Electronic Commerce

MEDIA:

Logo
Logo
Photo
Photo
“In the wake of changes in our economies, businesses, and communities over the last three years, WEX and our global customers and partners have continually adapted and evolved, and we aim to support them as they embrace initiatives such as transitioning to electric vehicles or educating consumers about the value of Health Savings Accounts,” said Melissa Smith, Chair and CEO, WEX (NYSE: WEX). (Photo: Business Wire)

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass.–(BUSINESS WIRE)–
ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the compensation committee of the Company’s Board of Directors (the “Compensation Committee”) approved, effective as of July 31, 2023, grants of non-qualified stock options to purchase an aggregate of 20,600 shares of its common stock and restricted stock units (“RSUs”) covering 10,300 shares of its common stock under the Inducement Plan to two new employees.

The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of ImmunoGen (or following a bona fide period of non-employment), as an inducement material to such individual’s entering into employment with ImmunoGen, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.

The options have an exercise price of $17.82 per share, which is equal to the closing price of ImmunoGen’s common stock on the Nasdaq Global Select Market on July 31, 2023. Each option will vest as to 25% of the shares underlying such option on the first anniversary of the grant date and as to an additional 6.25% of the shares underlying the option quarterly thereafter, subject to each employee’s continued employment on each vesting date. Each RSU will vest as to 25% of the shares underlying the RSU award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the RSU award annually thereafter, subject to each employee’s continued employment on each vesting date. Each option and RSU is subject to the terms and conditions of the Inducement Plan and the terms and conditions of a stock option agreement and an RSU agreement covering the respective grants.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

INVESTOR RELATIONS CONTACT

ImmunoGen

Anabel Chan

781-895-0600

[email protected]

MEDIA CONTACTS

ImmunoGen

Courtney O’Konek

781-895-0600

[email protected]

OR

FTI Consulting

Robert Stanislaro

212-850-5657

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Oncology

MEDIA:

Logo
Logo

Angel Oak Financial Strategies Income Term Trust Declares August 2023 Distribution

Angel Oak Financial Strategies Income Term Trust Declares August 2023 Distribution

ATLANTA–(BUSINESS WIRE)–
Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.095 per share for the month of August 2023. The record date for the distribution is August 17, 2023, and the payable date is August 31, 2023. The Fund will trade ex-distribution on August 16, 2023.

The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Fund’s investment experience during its fiscal year and will be made after the Fund’s year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes.

ABOUT FINS

Led by Angel Oak’s experienced financial services team, FINS invests predominantly in U.S. financial sector debt as well as selective opportunities across financial sector preferred and common equity. Under normal circumstances, at least 50% of FINS’ portfolio is publicly rated investment grade or, if unrated, judged to be of investment grade quality by Angel Oak.

ABOUT ANGEL OAK CAPITAL ADVISORS, LLC

Angel Oak Capital Advisors is an investment management firm focused on providing compelling fixed-income investment solutions to its clients. Backed by a value-driven approach, Angel Oak Capital Advisors seeks to deliver attractive, risk-adjusted returns through a combination of stable current income and price appreciation. Its experienced investment team seeks the best opportunities in fixed income, with a specialization in mortgage-backed securities and other areas of structured credit.

Information regarding the Fund and Angel Oak Capital Advisors can be found at www.angeloakcapital.com.

Past performance is neither indicative nor a guarantee of future results. Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information please contact your investment representative or Destra Capital Advisors LLC at 877.855.3434.

© 2023 Angel Oak Capital Advisors, which is the investment adviser to the Angel Oak Financial Strategies Income Term Trust.

Randy Chrisman, Chief Marketing & Corporate IR Officer, Angel Oak Capital Advisors

404-953-4969

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

On to Release Second Quarter Results on Tuesday, August 15, 2023

On to Release Second Quarter Results on Tuesday, August 15, 2023

ZURICH, Switzerland–(BUSINESS WIRE)–
Swiss performance sportswear brand On (NYSE: ONON) announced today that the Company will release its second quarter 2023 financial results on Tuesday, Aug. 15, 2023 before U.S. financial markets open.

The Company’s management will host an earnings conference call and webcast at 8 a.m. U.S. Eastern Time on Aug. 15, 2023 (2 p.m. Central European Time). To access the live conference call by telephone, please dial the following numbers:

United States: +1 646 307 19 63

United Kingdom: +44 203 481 42 47

Switzerland: +41 43 210 51 63

No access code necessary.

Additionally, a live webcast of the conference call will be available on the Company’s investor relations website and via the following link. Following the call, a recording will be available on the Company’s website.

About On

On was born in the Swiss Alps with one goal: to revolutionize the sensation of running by empowering all to run on clouds. Thirteen years after market launch, On delivers industry-disrupting innovation in premium footwear, apparel and accessories for high-performance running, outdoor and all-day activities. Fueled by customer-recommendation, On’s award-winning CloudTec® innovation, purposeful design and groundbreaking strides in sportswear’s circular economy have attracted a fast-growing global fanbase — inspiring humans to explore, discover and dream on.

On is present in more than 60 countries globally and engages with a digital community on www.on.com.

Source: On

Category: Earnings

Investor Contact:

On Holding AG

Jerrit Peter

[email protected]

or

ICR, Inc.

Brendon Frey

[email protected]

Media Contact:

On Holding AG

Vesna Stimac

[email protected]

KEYWORDS: Switzerland Europe

INDUSTRY KEYWORDS: IOT (Internet of Things) Data Management Consumer Electronics Technology Other Sports Finance Apps/Applications Professional Services Sports Running Wearables/Mobile Technology Other Technology Outdoors Software Mobile/Wireless

MEDIA:

Logo
Logo

Wolfgang Wienand to Join Mettler Toledo Board of Directors

Wolfgang Wienand to Join Mettler Toledo Board of Directors

COLUMBUS, Ohio–(BUSINESS WIRE)–
Mettler-Toledo International Inc. (NYSE: MTD) announced today that Dr. Wolfgang Wienand has been appointed to its Board of Directors, effective November 1st, 2023.

Dr. Wienand is the Chief Executive Officer of Siegfried Holding AG (SIX: SFZN), a global leader in contract development and manufacturing (CDMO) for the pharmaceutical industry. He joined Siegfried in 2010 as Member of the Executive Committee, initially serving as Chief Scientific Officer, then as Chief Strategy Officer and later holding both positions in parallel before becoming CEO in 2019. Prior to Siegfried, Dr. Wienand held senior management positions at Evonik Industries AG, a leading global specialty chemicals company.

Robert F. Spoerry, Chair of the Board, stated, “Wolfgang brings highly relevant experience as the CEO of a very successful services provider to the pharmaceutical industry, a key end market for METTLER TOLEDO. His significant experience as CEO and leading global strategy and innovation, process development, and manufacturing, will provide very valuable perspectives to our business. We welcome Wolfgang and look forward to his contributions to our Board.”

METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

Adam Uhlman

Head of Investor Relations

METTLER TOLEDO

Direct: 614-438-4794

[email protected]

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Engineering Chemicals/Plastics Machine Tools, Metalworking & Metallurgy Manufacturing

MEDIA:

Logo
Logo

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and SAN DIEGO, Aug. 01, 2023 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that on August 1, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 275,000 shares of the Company’s common stock to one newly hired employee. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an inducement material to such individuals’ entering into employment with Zentalis, pursuant to Nasdaq Listing Rule 5635(c)(4).

The stock options have an exercise price of $26.25 per share, which is equal to the closing price of Zentalis’ common stock on The Nasdaq Global Market on the date of grant. The stock options have a 10-year term and will vest over four years, with 25% of the options vesting on the first anniversary of the vesting commencement date and the remaining 75% of the options vesting in equal monthly installments over the three years thereafter. Vesting of the stock options is subject to such employee’s continued service to Zentalis on each vesting date.

About Zentalis Pharmaceuticals

Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Utilizing its Integrated Discovery Engine, the Company is developing a focused pipeline of potentially best-in-class oncology candidates, which include azenosertib (ZN-c3), a WEE1 inhibitor for advanced solid tumors, ZN-d5, a BCL-2 inhibitor for hematologic malignancies and related disorders, and a heterobifunctional degrader of BCL-xL for solid and hematological malignancies. The Company is also leveraging its extensive experience and capabilities across cancer biology and medicinal chemistry to advance its research on protein degraders. Zentalis has operations in both New York and San Diego.

For more information, please visit www.zentalis.com. Follow Zentalis on Twitter at @ZentalisP and on LinkedIn at www.linkedin.com/company/zentalis-pharmaceuticals.

Contact:

Katie Beach Oltsik
Evoke Canale
[email protected]

 



Texas Pacific Land Corporation Announces Board Refreshment

Texas Pacific Land Corporation Announces Board Refreshment

Will nominate two new independent directors with relevant experience and expertise in energy, land and royalty management and executive leadership at the 2023 Annual Meeting

David E. Barry and John R. Norris III will retire from the Board at the 2023 Annual Meeting

Company enters into a Cooperation Agreement with Horizon Kinetics and SoftVest

DALLAS–(BUSINESS WIRE)–
Texas Pacific Land Corporation (NYSE: TPL) (the “Company” or “TPL”) today announced its slate of director nominees for election to the Company’s board of directors (the “Board”) at the 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”).

The Company will nominate two new independent directors, Marguerite Woung-Chapman and Robert Roosa, in addition to current director, Murray Stahl. The current directors and co-chairs of the Board, David E. Barry and John R. Norris III, have announced their intention to retire at the 2023 Annual Meeting and will not stand for reelection. The Board intends to announce new Board leadership following the 2023 Annual Meeting.

TPL’s new independent director nominees bring a strong and relevant mix of skills and experiences, as well as proven track records of value creation, which the Board believes will enhance its oversight of TPL’s strategy and performance:

  • Ms. Woung-Chapman has extensive energy sector executive experience, having worked at and with oil and gas companies for more than 30 years. Ms. Woung-Chapman currently serves as a member of the Board of Directors of Chord Energy (NASDAQ: CHRD) and Summit Midstream Partners (NYSE: SMLP). She previously served as Senior Vice President, General Counsel and Corporate Secretary of Energy XXI Gulf Coast, Inc.
  • Mr. Roosa brings deep oil and gas financial and executive experience to the Board and is currently Partner and Chief Executive Officer of Brigham Royalties, LLC. He was previously the Chief Executive Officer and a Director of Brigham Minerals, Inc., a public minerals company, from 2017 to 2022.

“We thank David and John for their dedication and years of service to TPL and its shareholders, during which time they helped oversee substantial growth and value creation. We wish them all the best,” said General Donald Cook, TPL director and chairperson of the Nominating and Governance Committee. “The Board looks forward to welcoming Marguerite and Robert. We believe the Company and its shareholders will benefit greatly from their relevant experience and expertise as we continue to execute TPL’s strategy and drive value for our shareholders.”

In connection with the Board changes, TPL has entered into a Cooperation Agreement (the “Cooperation Agreement”) with Horizon Kinetics LLC, SoftVest, L.P. and their affiliated funds (collectively, the “Investor Group”), which includes, among other things, certain voting commitments and standstill and nondisparagement provisions. The Cooperation Agreement will be filed on Form 8-K with the Securities and Exchange Commission. The Cooperation Agreement has no impact on the litigation pending in Delaware Chancery Court between TPL and the Investor Group.

Evercore is serving as financial advisor to TPL, Sidley Austin LLP is serving as legal advisor to TPL and Spotlight Advisors, LLC is serving as strategic advisor to TPL.

About Marguerite Woung-Chapman

Ms. Woung-Chapman currently serves as a member of the Board of Directors of Chord Energy (NASDAQ: CHRD) and Summit Midstream Partners (NYSE: SMLP). In 2018, Ms. Woung-Chapman served as Senior Vice President, General Counsel and Corporate Secretary of Energy XXI Gulf Coast, Inc., a NASDAQ-listed independent exploration and production company that was engaged in the development, exploitation and acquisition of oil and natural gas properties in the U.S. Gulf Coast region. Prior to that, from 2012 to 2017, Ms. Woung-Chapman served in various capacities at EP Energy Corporation, a private company that subsequently became an NYSE-listed independent oil and gas exploration and production company, including, among others, Senior Vice President, Land Administration, General Counsel and Corporate Secretary. Ms. Woung-Chapman began her career as a corporate attorney with El Paso Corporation (including its predecessors) and served in various capacities of increasing responsibility during her tenure from 1991 until 2012, including, among others, Vice President, Legal Shared Services, Corporate Secretary and Chief Governance Officer. She has a B.S. in Linguistics from Georgetown University and a J.D. from the Georgetown University Law Center.

About Robert Roosa

Robert M. Roosa is Partner and Chief Executive Officer of Brigham Royalties, LLC and previously served as the Chief Executive Officer since 2017 and director of Brigham Minerals since 2018 until it was acquired by Sitio Royalties Corporation in 2022. Mr. Roosa served as the President of Anthem Ventures, LLC, a family office, and assisted Mr. Brigham with a number of family ventures between January 2012 and January 2017. Mr. Roosa served various roles, including Director of Finance and Investor Relations, while at Brigham Exploration from 2006 until its sale to Statoil in December of 2011. From 2000 to 2006, Mr. Roosa held a series of positions at Exxon Mobil Corporation, an oil and gas company, in the Corporate Treasurer’s Department. Prior to 2000, Mr. Roosa worked for Cooper Industries, an electrical products manufacturing company, in its Corporate Controllers and Audit Groups and with the accounting firm Deloitte & Touche LLP in its audit function. Mr. Roosa graduated from Southern Methodist University with a Master of Business Administration and from the University of Texas at Austin with a Bachelor of Business Administration.

About Texas Pacific Land Corporation

Texas Pacific Land Corporation is one of the largest landowners in the State of Texas with approximately 874,000 acres of land in West Texas, with the majority of its ownership concentrated in the Permian Basin. The Company is not an oil and gas producer, but its surface and royalty ownership provide revenue opportunities throughout the life cycle of a well. These revenue opportunities include fixed fee payments for use of our land, revenue for sales of materials (caliche) used in the construction of infrastructure, providing sourced water and/or treated produced water, revenue from our oil and gas royalty interests, and revenues related to saltwater disposal on our land. The Company also generates revenue from pipeline, power line and utility easements, commercial leases and temporary permits related to a variety of land uses including midstream infrastructure projects and hydrocarbon processing facilities.

Investors:

TPL Investor Relations

[email protected]

Media:

Paul Caminiti / Nicholas Leasure

Reevemark

(212) 433-4600

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Commercial Building & Real Estate Energy Construction & Property Oil/Gas

MEDIA:

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) — The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below. The distributions are payable on September 1, 2023 to shareholders of record on August 11, 2023, with an ex-dividend date of August 10, 2023.

    Monthly Distribution
    Per Share
Fund NYSE Symbol Amount Change From Previous Month Percentage Change From Previous Month
PIMCO Corporate & Income Strategy Fund (NYSE: PCN) $0.112500
PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) $0.118800
PIMCO Global StocksPLUS® & Income Fund (NYSE: PGP) $0.069000
PIMCO High Income Fund (NYSE: PHK) $0.048000
PIMCO Strategic Income Fund, Inc. (NYSE: RCS) $0.051000
PCM Fund, Inc. (NYSE: PCM) $0.080000
PIMCO Income Strategy Fund (NYSE: PFL) $0.081400
PIMCO Income Strategy Fund II (NYSE: PFN) $0.071800
PIMCO Dynamic Income Fund (NYSE: PDI) $0.220500
PIMCO Dynamic Income Opportunities Fund (NYSE: PDO) $0.127900
PIMCO Municipal Income Fund (NYSE: PMF) $0.042000
PIMCO California Municipal Income Fund (NYSE: PCQ) $0.036000
PIMCO New York Municipal Income Fund (NYSE: PNF) $0.033500
PIMCO Municipal Income Fund II (NYSE: PML) $0.039500
PIMCO California Municipal Income Fund II (NYSE: PCK) $0.021500
PIMCO New York Municipal Income Fund II (NYSE: PNI) $0.029500
PIMCO Municipal Income Fund III (NYSE: PMX) $0.033000
PIMCO California Municipal Income Fund III (NYSE: PZC) $0.029500
PIMCO New York Municipal Income Fund III (NYSE: PYN) $0.024800
PIMCO Access Income Fund (NYSE: PAXS) $0.149400

Fund Distribution Information as of June 30, 2023:

Fund NYSE Symbol Current Amount Annualized current distribution rate expressed as a percentage of NAV as of 06/30/2023 Annualized current distribution rate expressed as a percentage of Market Price as of 06/30/2023
PIMCO Corporate & Income Strategy Fund (NYSE: PCN) $0.112500 12.09% 10.30%
PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) $0.118800 13.14% 10.18%
PIMCO Global StocksPLUS® & Income Fund (NYSE: PGP) $0.069000 11.31% 11.50%
PIMCO High Income Fund (NYSE: PHK) $0.048000 12.72% 11.52%
PIMCO Strategic Income Fund, Inc. (NYSE: RCS) $0.051000 14.17% 11.77%
PCM Fund, Inc. (NYSE: PCM) $0.080000 14.20% 9.97%
PIMCO Income Strategy Fund (NYSE: PFL) $0.081400 12.54% 11.93%
PIMCO Income Strategy Fund II (NYSE: PFN) $0.071800 12.54% 11.95%
PIMCO Dynamic Income Fund (NYSE: PDI) $0.220500 15.30% 14.11%
PIMCO Dynamic Income Opportunities Fund (NYSE: PDO) $0.127900 12.08% 11.75%
PIMCO Municipal Income Fund (NYSE: PMF) $0.042000 5.17% 4.90%
PIMCO California Municipal Income Fund (NYSE: PCQ) $0.036000 4.14% 4.41%
PIMCO New York Municipal Income Fund (NYSE: PNF) $0.033500 4.50% 4.69%
PIMCO Municipal Income Fund II (NYSE: PML) $0.039500 5.29% 5.24%
PIMCO California Municipal Income Fund II (NYSE: PCK) $0.021500 3.90% 4.34%
PIMCO New York Municipal Income Fund II (NYSE: PNI) $0.029500 4.12% 4.66%
PIMCO Municipal Income Fund III (NYSE: PMX) $0.033000 4.81% 4.92%
PIMCO California Municipal Income Fund III (NYSE: PZC) $0.029500 4.57% 4.60%
PIMCO New York Municipal Income Fund III (NYSE: PYN) $0.024800 4.35% 4.73%
PIMCO Access Income Fund (NYSE: PAXS) $0.149400 12.04% 12.15%

Distribution rates are not performance and are calculated by annualizing the current distribution per share announced in this press release and dividing by the NAV or Market Price, as applicable, as of the reported date. A Fund’s distribution rate may be affected by numerous factors, including changes in realized and projected market returns, Fund performance, and other factors. There can be no assurance that a change in market conditions or other factors will not result in a change in a Fund’s distribution rate at a future time. Distributions may be comprised of ordinary income, net capital gains, and/or a return of capital (“ROC”) of your investment in a Fund. Because the distribution rate may include a ROC, it should not be confused with yield or performance.

Average Annual Total Returns Based on NAV and Market Price (“MKT”) of Common Shares as of June 30, 2023:

Fund NYSE Symbol Inception Date   1 Year 5 Year 10 Year Since Inception
PIMCO Corporate & Income Strategy Fund

(NYSE: PCN)

12/21/2001

NAV 9.77% 5.11% 7.84% 10.39%
MKT 17.14% 3.57% 7.65% 10.28%
PIMCO Corporate & Income Opportunity Fund

(NYSE: PTY)

12/27/2002

NAV 11.49% 6.15% 9.41% 12.24%
MKT 27.06% 5.95% 8.79% 12.25%
PIMCO Global StocksPLUS® & Income Fund

(NYSE: PGP)

5/31/2005

NAV 13.15% 4.04% 8.06% 10.06%
MKT 2.32% -4.39% -0.30% 5.97%
PIMCO High Income Fund

(NYSE: PHK)

4/30/2003

NAV 8.34% 4.98% 9.05% 10.12%
MKT 9.20% 0.72% 3.63% 7.63%
PIMCO Strategic Income Fund, Inc.

(NYSE: RCS)

2/24/1994

NAV 5.55% 0.73% 3.92% 7.21%
MKT 14.43% -2.48% 3.30% 7.32%
PCM Fund, Inc.

(NYSE: PCM)

9/2/1993

NAV 0.45% 2.57% 5.76% 8.17%
MKT 16.30% 6.42% 8.50% 8.78%
PIMCO Income Strategy Fund

(NYSE: PFL)

8/29/2003

NAV 4.71% 3.71% 6.45% 6.18%
MKT 2.64% 3.05% 6.59% 6.08%
PIMCO Income Strategy Fund II

(NYSE: PFN)

10/29/2004

NAV 5.00% 3.32% 6.61% 5.39%
MKT 2.62% 3.14% 6.78% 5.36%
PIMCO Dynamic Income Fund

(NYSE: PDI)

5/30/2012

NAV 4.85% 2.33% 7.64% 10.28%
MKT 7.22% 1.52% 8.75% 10.28%
PIMCO Dynamic Income Opportunities Fund

(NYSE: PDO)

1/29/2021

NAV -1.07% -6.09%
MKT 13.17% -5.39%
PIMCO Municipal Income Fund

(NYSE: PMF)

6/29/2001

NAV 0.24% 0.38% 4.07% 5.32%
MKT -5.48% 0.42% 3.89% 4.90%
PIMCO California Municipal Income Fund

(NYSE: PCQ)

6/29/2001

NAV 1.59% 0.69% 3.98% 5.30%
MKT -33.14% -5.79% 1.99% 4.33%
PIMCO New York Municipal Income Fund

(NYSE: PNF)

6/29/2001

NAV 0.32% -0.43% 3.54% 3.80%
MKT -1.39% -2.47% 3.07% 3.36%
PIMCO Municipal Income Fund II

(NYSE: PML)

6/28/2002

NAV 0.43% 0.64% 4.08% 4.47%
MKT -10.27 -1.67% 3.56% 4.14%
PIMCO California Municipal Income Fund II

(NYSE: PCK)

6/28/2002

NAV 1.39% 0.19% 4.14% 3.35%
MKT -8.83% -1.64% 0.78% 2.22%
PIMCO New York Municipal Income Fund II

(NYSE: PNI)

6/28/2002

NAV 1.32% 0.05% 3.89% 3.89%
MKT -8.54% -1.91% 1.49% 2.96%
PIMCO Municipal Income Fund III

(NYSE: PMX)

10/31/2002

NAV 0.25% 0.26% 4.39% 4.24%
MKT -7.56% -1.70% 3.06% 3.69%
PIMCO California Municipal Income Fund III

(NYSE: PZC)

10/31/2002

NAV 1.36% 0.62% 4.06% 3.57%
MKT -1.84% -1.08% 3.02% 3.15%
PIMCO New York Municipal Income Fund III

(NYSE: PYN)

10/31/2002

NAV 0.54% -0.39% 3.31% 2.51%
MKT -15.41% -2.47% 1.50% 1.82%
PIMCO Access Income Fund

(NYSE: PAXS)

1/31/2022

NAV -0.78% -8.90%
MKT 7.53% -9.10%

Performance for periods of more than one year is annualized.

Past performance is not a guarantee or a reliable indicator of future results. There can be no assurance that a Fund or any investment strategy will achieve its investment objectives or structure its investment portfolio as anticipated. An investment in a Fund involves risk, including loss of principal. Investment return and the value of shares will fluctuate. Shares may be worth more or less than original purchase price. Due to market volatility, current performance may be lower or higher than average annual returns shown. Returns are calculated by determining the percentage change in net asset value (“NAV”) or market price (as applicable) of the Fund’s common shares in the specific period. The calculation assumes that all dividends and distributions, if any, have been reinvested. NAV and market price returns do not reflect broker sales charges or commissions in connection with the purchase or sales of Fund shares and includes the effect of any expense reductions. Returns for a period of less than one year are not annualized. Returns for a period of more than one year represent the average annual return. Performance at market price will differ from results at NAV. Although market price returns typically reflect investment results over time, during shorter periods returns at market price can also be influenced by factors such as changing views about a Fund, market conditions, supply and demand for a Fund’s shares or changes in Fund dividends and distributions.


Additional Information

Distributions from PMF, PML, PMX, PCQ, PCK, PZC, PNF, PNI and PYN are generally exempt from regular federal income taxes (i.e., excluded from gross income for federal income tax purposes but not necessarily exempt from the federal alternative minimum tax). In addition, distributions from PCQ, PCK and PZC are also generally exempt from California state income taxes, and distributions from PNF, PNI and PYN are generally exempt from New York State and city income taxes. There can be no assurance that all distributions paid by these Funds will be exempt from federal income taxes or applicable state or local income taxes.

Distributions may include ordinary income, net capital gains and/or a return of capital. Generally, a return of capital occurs when the amount distributed by a Fund includes a portion of (or is comprised entirely of) your investment in the Fund in addition to (or rather than) your pro-rata portion of the Fund’s net income or capital gains. A Fund’s distributions in any period may be more or less than the net return earned by the Fund on its investments, and therefore should not be used as a measure of performance or confused with “yield” or “income.” A return of capital is not taxable; rather it reduces a shareholder’s tax basis in his or her shares of a Fund.

If a Fund estimates that a portion of a distribution may be comprised of amounts from sources other than net investment income, as determined in accordance with its internal accounting records and related accounting practices, the Fund will notify shareholders of the estimated composition of such distribution through a Section 19 Notice. For these purposes, a Fund estimates the source or sources from which a distribution is paid, to the close of the period as of which it is paid, in reference to its internal accounting records and related accounting practices. If, based on such accounting records and practices, it is estimated that a particular distribution does not include capital gains or paid-in surplus or other capital sources, a Section 19 Notice generally would not be issued. It is important to note that differences exist between a Fund’s daily internal accounting records and practices, the Fund’s financial statements presented in accordance with U.S. GAAP, and recordkeeping practices under income tax regulations. For instance, a Fund’s internal accounting records and practices may take into account, among other factors, tax-related characteristics of certain sources of distributions that differ from treatment under U.S. GAAP. Examples of such differences may include, among others, the treatment of paydowns on mortgage-backed securities purchased at a discount and periodic payments under interest rate swap contracts. Accordingly, among other consequences, it is possible that a Fund may not issue a Section 19 Notice in situations where the Fund’s financial statements prepared later and in accordance with U.S. GAAP and/or the final tax character of those distributions might later report that the sources of those distributions included capital gains and/or a return of capital. Please visit www.pimco.com for the most recent Section 19 Notice, if applicable, and most recent shareholder reports for additional information regarding the estimated composition of distributions. Final determination of a distribution’s tax character will be provided to shareholders when such information is available.

The tax treatment and characterization of a Fund’s distributions may vary significantly from time to time because of the varied nature of the Fund’s investments. For example, a Fund may enter into opposite sides of multiple interest rate swaps or other derivatives with respect to the same underlying reference instrument (e.g., a 10-year U.S. treasury) that have different effective dates with respect to interest accrual time periods for the principal purpose of generating distributable gains (characterized as ordinary income for tax purposes) that are not part of the Fund’s duration or yield curve management strategies. In such a “paired swap transaction”, the Fund would generally enter into one or more interest rate swap agreements whereby the Fund agrees to make regular payments starting at the time the Fund enters into the agreements equal to a floating interest rate in return for payments equal to a fixed interest rate (the “initial leg”). The Fund would also enter into one or more interest rate swap agreements on the same underlying instrument, but take the opposite position (i.e., in this example, the Fund would make regular payments equal to a fixed interest rate in return for receiving payments equal to a floating interest rate) with respect to a contract whereby the payment obligations do not commence until a date following the commencement of the initial leg (the “forward leg”).

A Fund may engage in investment strategies, including those that employ the use of derivatives, to, among other things, seek to generate current, distributable income, even if such strategies could potentially result in declines in the Fund’s NAV. A Fund’s income and gain-generating strategies, including certain derivatives strategies, may generate current income and gains taxable as ordinary income sufficient to support monthly distributions even in situations when the Fund has experienced a decline in net assets due to, for example, adverse changes in the broad U.S. or non-U.S. equity markets or the Fund’s debt investments, or arising from its use of derivatives. Because some or all of these transactions may generate capital losses without corresponding offsetting capital gains, portions of a Fund’s distributions recognized as ordinary income for tax purposes (such as from paired swap transactions) may be economically similar to a taxable return of capital when considered together with such capital losses. The tax treatment of certain derivatives in which a Fund invests may be unclear and thus subject to recharacterization. Any recharacterization of payments made or received by a Fund pursuant to derivatives potentially could affect the amount, timing or character of Fund distributions. In addition, the tax treatment of such investment strategies may be changed by regulation or otherwise.

The common shares of the Funds trade on the New York Stock Exchange. As with any stock, the price of a Fund’s common shares will fluctuate with market conditions and other factors. If you sell your common shares of a Fund, the price received may be more or less than your original investment. Shares of closed-end investment management companies, such as the Funds, frequently trade at a discount from their net asset value and may trade at a price that is less than the initial offering price and/or the net asset value of such shares. Further, if a Fund’s shares trade at a price that is more than the initial offering price and/or the net asset value of such shares, including at a substantial premium and/or for an extended period of time, there is no assurance that any such premium will be sustained for any period of time and will not decrease, or that the shares will not trade at a discount to net asset value thereafter.

The Funds’ daily New York Stock Exchange closing market prices, net asset values per share, as well as other information, including updated portfolio statistics and performance are available at pimco.com/closedendfunds or by calling the Funds’ shareholder servicing agent at (844) 33-PIMCO. Updated portfolio holdings information about a Fund will be available approximately 15 calendar days after such Fund’s most recent fiscal quarter end, and will remain accessible until such Fund files a shareholder report or a publicly available Form N-PORT for the period that includes the date of the information.

A Fund’s shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not insured by the FDIC, the Federal Reserve Board or any other government agency. You may lose money by investing in a Fund. Certain risks associated with investing in a Fund are summarized below.

An investor should consider, among other things, a Fund’s investment objectives, risks, charges and expenses carefully before investing. A Fund’s annual report contains (or will contain) this and other information about the Fund.

A word about risk:

Investing in the bond market is subject to risks, including market, interest rate, issuer, credit, inflation risk, and liquidity risk. The value of most bonds and bond strategies are impacted by changes in interest rates. Bonds and bond strategies with longer durations tend to be more sensitive and volatile than those with shorter durations; bond prices generally fall as interest rates rise, and low interest rate environments increase this risk. Reductions in bond counterparty capacity may contribute to decreased market liquidity and increased price volatility. Bond investments may be worth more or less than the original cost when redeemed. Bank loans are often less liquid than other types of debt instruments and general market and financial conditions may affect the prepayment of bank loans, and as such the prepayments cannot be predicted with accuracy. There is no assurance that the liquidation of any collateral from a secured bank loan would satisfy the borrower’s obligation, or that such collateral could be liquidated. Contingent Convertible (“Coco”) Bonds are bonds that are converted into equity of the issuing company if a pre-specified trigger occurs. Co-cos are subject to a different type of risk from traditional bonds and may result in a partial or total loss of value or may be converted into shares of the issuing company which may also have suffered a loss in value. Collateralized Loan Obligations (CLOs) may involve a high degree of risk and are intended for sale to qualified investors only. Investors may lose some or all of the investment and there may be periods where no cash flow distributions are received. CLOs are exposed to risks such as credit, default, liquidity, management, volatility, interest rate, and credit risk. Convertible securities may be called before intended, which may have an adverse effect on investment objectives. Floating rate loans are not traded on an exchange and are subject to significant credit, valuation and liquidity risk. A Fund may invest without limit in below investment grade debt securities (commonly referred to as “high yield” securities or “junk bonds”), including securities of stressed and distressed issuers. High-yield, lower-rated, securities involve greater risk than higher-rated securities; portfolios that invest in them may be subject to greater levels of credit and liquidity risk than portfolios that do not. Investments in residential/commercial mortgage loans and commercial real estate debt are subject to risks that include prepayment, delinquency, foreclosure, risks of loss, servicing risks and adverse regulatory developments, which risks may be heightened in the case of non-performing loans. A Fund will also have exposure to such risks through its investments in mortgage and asset-backed securities, which are highly complex instruments that may be sensitive to changes in interest rates and subject to early repayment risk. Income from municipal bonds is exempt from federal income tax and may be subject to state and local taxes and at times the alternative minimum tax; a strategy concentrating in a single or limited number of states is subject to greater risk of adverse economic conditions and regulatory changes. Structured products such as collateralized debt obligations are also highly complex instruments, typically involving a high degree of risk; use of these instruments may involve derivative instruments that could lose more than the principal amount invested. Sovereign securities are generally backed by the issuing government, obligations of U.S. Government agencies and authorities are supported by varying degrees but are generally not backed by the full faith of the U.S. Government; portfolios that invest in such securities are not guaranteed and will fluctuate in value. Concentration of assets in one or a few sectors may entail greater risk than a fully diversified portfolio and should be considered as only part of a diversified portfolio. Investing in foreign-denominated and/or -domiciled securities may involve heightened risk due to currency fluctuations, and economic and political risks, which may be enhanced in emerging markets. The use of leverage may cause a portfolio to liquidate positions when it may not be advantageous to do so to satisfy its obligations or to meet segregation requirements. Leverage, including borrowing, may cause a portfolio to be more volatile than if the portfolio had not been leveraged. Derivatives may involve certain costs and risks, such as liquidity, interest rate, market, credit, management and the risk that a position could not be closed when most advantageous. Investing in derivatives could lose more than the amount invested. Each of PDO, PNF and PYN is non-diversified, which means that it may invest its assets in a smaller number of issuers than a diversified Fund.

Closed-end funds, unlike open-end funds, are not continuously offered. After the initial public offering, shares are sold on the open market through a stock exchange. Closed-end funds may be leveraged and carry various risks depending upon the underlying assets owned by a fund. Investment policies, management fees and other matters of interest to prospective investors may be found in each closed-end fund annual and semi-annual report. For additional information, please contact your investment professional or call 1-844-337-4626.

About PIMCO

PIMCO was founded in 1971 in Newport Beach, California and is one of the world’s premier fixed income investment managers. Today we have offices across the globe and 3,000+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz S.E., a leading global diversified financial services provider.

Except for the historical information and discussions contained herein, statements contained in this news release constitute forward-looking statements. These statements may involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including the performance of financial markets, the investment performance of PIMCO’s sponsored investment products and separately managed accounts, general economic conditions, future acquisitions, competitive conditions and government regulations, including changes in tax laws. Readers should carefully consider such factors. Further, such forward-looking statements speak only on the date at which such statements are made. PIMCO undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statement.

This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America LLC in the United States and throughout the world. PIMCO Investments LLC, 1633 Broadway, New York, NY 10019, is a company of PIMCO. ©2023, PIMCO.

For information on PIMCO Closed-End Funds:
Financial Advisors: (800) 628-1237
Shareholders: (844) 337-4626 or (844) 33-PIMCO
PIMCO Media Relations: (212) 597-1054



TPG RE Finance Trust, Inc. Reports Operating Results for the Quarter Ended June 30, 2023

TPG RE Finance Trust, Inc. Reports Operating Results for the Quarter Ended June 30, 2023

NEW YORK–(BUSINESS WIRE)–
TPG RE Finance Trust, Inc. (NYSE: TRTX) (“TRTX” or the “Company”) reported its operating results for the quarter ended June 30, 2023.

Regarding second quarter results, Doug Bouquard, Chief Executive Officer of TRTX, said: “We continue to actively manage our investment portfolio as evidenced by our recent asset resolutions, a strong liquidity position and a durable capital structure that allows us to navigate an ever-evolving market environment. Our integration with the global TPG franchise provides us with valuable market insights that enable us to make well-informed investment decisions to maximize shareholder value.”

SECOND QUARTER 2023 ACTIVITY

  • Recognized GAAP net (loss) attributable to common stockholders of ($72.7) million, or ($0.94) per common share, based on a diluted weighted average share count of 77.4 million common shares. Book value per common share was $13.10 as of June 30, 2023.

  • Declared on June 14, 2023 a cash dividend of $0.24 per share of common stock which was paid on July 25, 2023 to common stockholders of record as of June 28, 2023. The Company paid on June 30, 2023 to stockholders of record as of June 20, 2023 a quarterly dividend on its 6.25% Series C Cumulative Redeemable Preferred Stock of $0.3906 per share.

  • Received loan repayments of $279.1 million, including four full loan repayments totaling $236.0 million, involving the following property types: 78.4% multifamily, 17.8% office, 3.1% mixed-use, and 0.7% hotel.

  • Sold an office loan with an unpaid principal balance of $71.3 million for $47.8 million, resulting in a loss on sale of $24.1 million, including transaction costs of $0.6 million.

  • Acquired through a negotiated deed in lieu of foreclosure an office property with a carrying value at June 30, 2023 of $45.2 million and a fair value at closing of $46.0 million.

  • Weighted average risk rating of the Company’s loan portfolio was 3.2 as of June 30, 2023, unchanged from March 31, 2023.

  • Carried at quarter-end an allowance for credit losses of $278.3 million, an increase of $55.9 million from $222.4 million as of March 31, 2023. Of the $278.3 million allowance for credit losses, $176.2 million is a specific reserve relating to five loans. The quarter-end allowance equals 572 basis points of total loan commitments as of June 30, 2023 compared to 420 basis points as of March 31, 2023.

  • Held five non-accrual loans with a total amortized cost of $546.7 million, as compared to six loans at March 31, 2023 with a total amortized cost of $550.1 million.

  • Ended the quarter with $542.9 million of total liquidity, comprised of: $289.1 million of cash-on-hand available for investment, net of $18.4 million held to satisfy liquidity covenants under the Company’s secured financing agreements; undrawn capacity under secured financing arrangements of $28.4 million; undrawn capacity under asset-specific financing arrangements and secured revolving credit facility of $0.3 million; and $206.7 million of reinvestment capacity in one of the Company’s three CRE CLOs.

  • Non-mark-to-market debt represented 71.7% of total borrowings at June 30, 2023.

SUBSEQUENT EVENTS

  • Closed one first mortgage loan with a total loan commitment of $43.6 million and initial funding of $37.2 million. The first mortgage loan is secured by two select service hotels.

  • Sold a mixed-use loan with an unpaid principal balance of $128.5 million, net of lender-held operating reserves, which carried a “5” risk rating as of June 30, 2023.

The Company issued a supplemental presentation detailing its second quarter 2023 operating results, which can be viewed at http://investors.tpgrefinance.com/.

CONFERENCE CALL AND WEBCAST INFORMATION

The Company will host a conference call and webcast to review its financial results with investors and other interested parties at 9:00 a.m. ET on Wednesday, August 2, 2023. To participate in the conference call, callers from the United States and Canada should dial +1 (877) 407-9716, and international callers should dial +1 (201) 493-6779, ten minutes prior to the scheduled call time. The webcast may also be accessed live by visiting the Company’s investor relations website at http://investors.tpgrefinance.com/event.

REPLAY INFORMATION

A replay of the conference call will be available after 12:00 p.m. ET on Wednesday, August 2, 2023 through 11:59 p.m. ET on Wednesday, August 16, 2023. To access the replay, listeners may use +1 (844) 512-2921 (domestic) or +1 (412) 317-6671 (international). The passcode for the replay is 13737305. The replay will be available on the Company’s website for one year after the call date.

ABOUT TRTX

TPG RE Finance Trust, Inc. is a commercial real estate finance company that originates, acquires, and manages primarily first mortgage loans secured by institutional properties located in primary and select secondary markets in the United States. The Company is externally managed by TPG RE Finance Trust Management, L.P., a part of TPG Real Estate, which is the real estate investment platform of global alternative asset management firm TPG Inc. (NASDAQ: TPG). For more information regarding TRTX, visit https://www.tpgrefinance.com/.

FORWARD-LOOKING STATEMENTS

This earnings release contains “forward‐looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward‐looking statements are subject to various risks and uncertainties, including, without limitation, statements relating to the performance of the investments of TPG RE Finance Trust, Inc. (the “Company” or “TRTX”); global economic trends and economic conditions, including heightened inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, stress to the commercial banking systems of the U.S. and Western Europe, labor shortages, currency fluctuations and challenges in global supply chains; the Company’s ability to originate loans that are in the pipeline and under evaluation by the Company; financing needs and arrangements; and the risks, uncertainties and factors set forth under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as such risk factors may be updated from time to time in the Company’s periodic filings with the Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov. Forward‐looking statements are generally identifiable by use of forward‐looking terminology such as “may,” “will,” “should,” “potential,” “intend,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “believe,” “could,” “project,” “predict,” “continue” or other similar words or expressions. Forward‐looking statements are based on certain assumptions, discuss future expectations, describe existing or future plans and strategies, contain projections of results of operations, liquidity and/or financial condition or state other forward‐looking information. Statements, among others, relating to the Company’s ability to generate future growth and deliver value and returns, the Company’s continued focus on proactive management of the Company’s loan portfolio, market outlook, the TPG global franchise, market insights, the Company’s ability to make well-informed decisions and the Company’s focus on maximizing shareholder value are forward-looking statements, and the Company cannot assure you that TRTX will achieve such results. The ability of TRTX to predict future events or conditions or their impact or the actual effect of existing or future plans or strategies is inherently uncertain. Although the Company believes that such forward‐looking statements are based on reasonable assumptions, actual results and performance in the future could differ materially from those set forth in or implied by such forward‐looking statements. You are cautioned not to place undue reliance on these forward‐looking statements, which reflect the Company’s views only as of the date of this earnings release. Except as required by law, neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward‐looking statements appearing in this earnings release. The Company does not undertake any obligation to update any forward-looking statements contained in this earnings release as a result of new information, future events or otherwise. Past performance is not indicative nor a guarantee of future returns. Yield data are shown for illustrative purposes only and have limitations when used for comparison or for other purposes due to, among other matters, volatility, credit or other factors.

INVESTOR RELATIONS CONTACT

+1 (212) 405-8500

[email protected]

MEDIA CONTACT

TPG RE Finance Trust, Inc.

Courtney Power

+1 (415) 743-1550

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

The Allstate Corporation Announces Availability of Second Quarter 2023 Results

The Allstate Corporation Announces Availability of Second Quarter 2023 Results

NORTHBROOK, Ill.–(BUSINESS WIRE)–
The Allstate Corporation (NYSE: ALL) has filed a Form 8-K reporting its financial results for the quarter ended June 30, 2023. You can find the Form 8-K, including the earnings release and investor supplement, as well as the quarterly Form 10-Q, on the company’s page at sec.gov. These materials will be available by approximately 5 p.m. Eastern at www.allstateinvestors.com.

The Allstate Corporation will host a conference call and webcast at 11 a.m. Eastern on Wednesday, Aug. 2, to discuss second quarter results. You can access the webcast at www.allstateinvestors.com, where a replay will also be posted.

To get alerts about Allstate, enroll your email address on the “Email Alerts” section of www.allstateinvestors.com. You can also get RSS feeds of news releases there.

Financial information, including material announcements about The Allstate Corporation, is routinely posted on www.allstateinvestors.com.

Al Scott

(847) 402-5600

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Professional Services Insurance Finance

MEDIA:

Logo
Logo